Frailty and outcomes after bispecific T-cell engager therapy for patients with relapsed/refractory multiple myeloma Meeting Abstract


Authors: Adegbite, B. O.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; Chung, D. J.; Landau, H. J.; Scordo, M.; Hassoun, H.; Maclachlan, K. H.; Shah, U. A.; Hultcrantz, M.; Hamadeh, I. S.; Giralt, S.; Mailankody, S.; Usmani, S. Z.; Hashmi, H.
Abstract Title: Frailty and outcomes after bispecific T-cell engager therapy for patients with relapsed/refractory multiple myeloma
Meeting Title: 66th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 144
Issue: Suppl. 1
Meeting Dates: 2024 Dec 7-10
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2024-11-05
Start Page: 4735
End Page: 4736
Language: English
ACCESSION: WOS:001416739600039
DOI: 10.1182/blood-2024-201824
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1070 Giralt
  2. Hani Hassoun
    339 Hassoun
  3. Heather Jolie Landau
    437 Landau
  4. Alexander Meyer Lesokhin
    381 Lesokhin
  5. David Chung
    250 Chung
  6. Michael Scordo
    388 Scordo
  7. Neha Sanat Korde
    239 Korde
  8. Gunjan Lalitchandra Shah
    447 Shah
  9. Urvi A Shah
    202 Shah
  10. Carlyn Rose Tan
    145 Tan
  11. Saad Zafar Usmani
    343 Usmani
  12. Issam S. Hamadeh
    25 Hamadeh
  13. Sridevi Rajeeve
    44 Rajeeve
  14. Eric Jurgens
    20 Jurgens
  15. Hamza Hashmi
    63 Hashmi
  16. Kevin Charles Miller
    14 Miller